Table 3.
Variable | Foot Pain >4 (n = 22) |
Peripheral Neuropathy (n = 49) |
Foot Deformity (n = 60) |
≥2 Problems (n = 31) |
---|---|---|---|---|
Frailty category | ||||
Nonfrail | Reference | Reference | Reference | Reference |
Prefrail | 2.1 (0.52–8.6) | 3.2 (0.99–11) | 2.0 (0.72–5.4) | 4.6 (1.2–19) |
Frail | 17.0 (1.6–181)a | 13.3 (1.4–132)a | 7.7 (0.86–68)b | 27.8 (2.6–298)a,c |
Weaknessd | 17.9 (3.2–101)a | 6.5 (1.3–33)a | 6.2 (1.3–29)b | 11.4 (2.1–61 )a |
Exhaustion | 9.7 (1.8–54)a | 5.7 (1.1–28)a | 3.9 (0.81–19) | 9.1 (1.7–48)a |
Slowness | 1.2 (0.31–4.8) | 1.4 (0.45–4.2) | 1.0 (0.38–2.9) | 1.3 (.41–4.3) |
Low activity | 1.5 (0.34–7.0) | 1.2 (0.30–4.6) | 1.4 (0.40–4.9) | 1.9 (.48–7.9) |
Mobility-Tiredness Scale score ≤5 | 3.3 (0.84–13) | 1.3 (0.45–3.9) | 1.1 (0.45–2.9) | 2.6 (.79–8.4) |
Falls Efficacy Scale-International score >25 | 13.3 (3.1–56)a | 5.9 (1.8–19)a | 5.0 (1.6–15)a | 7.7 (2.2–27)a |
History of falle | 2.6 (0.76–9.0) | 2.4 (0.81–7.2) | 1.0 (0.39–2.8) | 2.1 (0.65–6.4) |
Fall incidence (incidence rate ratio [95% Cl])f | 1.4(0.60–3.1) | 1.4 (0.73–2.8) | 1.3 (0.66–2.4) | 1.5 (0.76–3.1) |
Note: Participants with a foot problem can have more than one problem; the comparison group consisted of 27 participants with no foot problem. Odds ratios (95% Cls) are reported except where indicated otherwise, all adjusted for age.
Abbreviation: Cl, confidence interval.
Significantly increased (P < .05) odds versus those with no foot problem.
Linear trend over frailty categories: P < .05.
Linear trend over frailty categories: P < .01.
Fried criterion unintended weight loss odds ratio not defined due to no participants with weight lossandno foot problem.
History of at least one fall reported in the 6 months before baseline (eight participants missing fallhistory).
Incidence of falls during 6-month follow-up (eight dropouts missing fall incidence).